We're excited to announce that submissions are now open for speaking presentations, panel discussions, and workshops at the ISPE Singapore Conference & Exhibition 2025, happening 27-29 August 2025 at Suntec Singapore.
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
In this session, we delve into the transformative impact of AI on sterile filling lines in pharmaceutical manufacturing. The discussion will focus on how AI-driven technologies enhance operational efficiency by improving precision, minimizing contamination risks, and optimizing production workflows. Attendees will gain insights into how machine learning algorithms are being used to streamline processes, ensure compliance with regulatory standards, and ultimately, deliver cost-effective, high-quality sterile filling lines.
Next generation of aseptic filling - highest flexibility meets latest regulations of Annex 1
Pre-sterilized packaging has been an integral part of pharmaceutical production for some time now. RTU syringes have become widely accepted in the market – mostly due to their huge benefits: With the focus being on the core process, i.e. on filling pharmaceutical products, upstream processes, such as washing and sterilizing, have been outsourced.
In recent years, RTU vials and cartridges have been following this trend. The prevention of glass-to-glass contact and the flexibility of processing various packaging materials on one machine also play a key role. But RTU containers
present some challenges as well: Sterile transfer into the cleanroom, inspection processes such as 100% IPC or the crimping process, for example.
In summary, flexible multi-product fill and finish lines offer pharmaceutical manufacturers the ability to adapt to changing market demands, improve production efficiency, reduce costs and maintain high-quality standards while ensuring regulatory compliance. These systems are a valuable asset for pharmaceutical companies seeking to remain
competitive and flexible in an evolving and demanding industry. In the pharmaceutical industry nothing stays the same for very long. There are always new processes, challenges, and developments to contend with. It’s important that you quickly adapt your approach to meet changing times
